Aronora
Blood & Organ Banks · Oregon, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1818 SW 4th Ave Ste 102, Portland, Orego...Phone Number
(503) 530-6842Website
www.aronorabio.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
5
2
About Aronora
Aronora, Inc. is focused on developing and commercializing innovative therapies for serious hematologic diseases, particularly those with significant unmet medical needs. The company is advancing first-in-class biologic drugs, including AB002 and AB023, which target unique mechanisms of action to address life-threatening blood conditions. Their primary clients include patients with end-stage renal disease requiring anticoagulation during hemodialysis, as well as individuals at risk for thrombotic complications from various medical conditions. Aronora's mission is to create safe and effective treatments that can significantly improve patient outcomes in the field of hematology.Explore more
Aronora Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aronora your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Aronora
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Aronora had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Aronora has new funding data
Check out if Aronora is spiking on competitors!
Website visits: Recent activity has been detected on your website
Aronora, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Aronora has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Aronora launches new products
Earning: See what the market has to say on Aronora recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Aronora
Compare insights from companies similar to Aronora, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aronora is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Aronora is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Aronora.
Aronora financials insights
Gather financial insights about Aronora, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$150K
Aronora Tech Stack
A closer look at the technologies used by Aronora
See more technologies
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Funding
Project
Spending/Investment, Funding
Aronora News & Media
Aronora Secures Investment From New York Blood Center
Aronora is Revolutionizing Blood Clot Treatment with Groundbreaking InnovationsAronora CEO Named National Academy of Inventors Fellow
Aronora co-founder and CEO Dr. Erik Tucker has been elected as Fellow of the National Academy of Inventors (NAI)Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting
Presentation to include clinical data from Aronora's phase 2 study of AB002, a first-in-class protein C activator enzyme that is being developed for the treatment and prevention of thrombotic and inflammatory diseases.Aronora Reports Positive Topline Data From Phase 2 Study of AB023 in Hemodialysis Patients
AB023 reduces dialyzer clotting compared to placebo during heparin-free dialysis, and continues to be safe and well tolerated
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aronora
Sign Up For FreeTo access detailed company insights
Aronora, Inc. is focused on developing and commercializing innovative therapies for serious hematologic diseases, particularly those with significant unmet medical needs. The company is advancing first-in-class biologic drugs, including AB002 and AB023, which target unique mechanisms of action to address life-threatening blood conditions. Their pri... Read More
